At-home diagnostics isn’t “a kit.” It’s an operating system. From the outside, it looks simple: order → kit arrives → collect → mail back. Behind the scenes, scaling that experience requires automation, reliability, and speed. In this conversation, Jeff Shattuck explains how DOT Corp uses automation, robotics, and AI to reduce the time from order to shipment, expanding what’s possible for home diagnostics and precision medicine. Key moments DotCorp transitioned from printing to healthcare logistics. AI and robotics are streamlining healthcare processes. At-home testing is becoming more prevalent post-COVID. Less invasive testing methods are emerging. Precision medicine will rely on at-home diagnostics. Accountable care programs are driving demand for home testing. Collaboration with major labs enhances service delivery. Patient empowerment is key in modern healthcare. Chapters 00:00 The Entrepreneurial Journey of DotCorp 05:19 Transforming Diagnostics: Home Testing Revolution 07:46 The Future of Precision Medicine and Home Testing Connect Jeff Shattuck: https://www.linkedin.com/in/jeffoshattuck/ Bradley Bostic: https://linktr.ee/BradleyBostic Boombostic Health: https://www.boombostichealth.com/ #boombostichealth #diagnostics #labtesting #digitalhealth #healthcareinnovation #populationhealth #valuebasedcare #precisionmedicine #healthcareoperations #supplychain #healthtech #hlth2025

Show Notes Healthcare keeps talking about AI, affordability, and outcomes… But most systems are still ignoring the front door that drives care decisions: diagnostics. Recorded In the Wild at HLTH 2025 in Las Vegas, Bradley Bostic sits down with James York (Chief Commercial Officer + Head of Government Affairs, Molecular Testing Labs) to unpack a hard truth: If you can’t make testing accessible, convenient, and trackable… you can’t build reliable care pathways. In this episode, James breaks down why diagnostics is a flywheel—the top-of-funnel that activates patients—and why “we have Quest/Labcorp, so we’re good” is the exact mindset keeping innovation stuck. He also shares how Molecular Testing Labs attacked the hardest access problem first (HIV/STI), what happened when they removed friction from PrEP care, and why lab-based at-home testing matters because it protects the integrity of the data (not just the experience). You’ll also hear a forward-looking take on self-collection, routine testing for chronic disease + wellness, cost transparency, and where AI could take us next—toward forecasting health like we forecast weather. What you’ll learn: Why James calls diagnostics “the flywheel” for activating patients The two stats that should change how leaders budget for labs (“70% of clinical decisions” vs “7% of spend” — as James cites) Why self-collected, lab-processed testing beats “rapid-only” testing when data/reporting matters How at-home testing can reduce stigma and improve public-health surveillance What “patient-as-decision-maker” healthcare could look like in the next 5–10 years If you care about prevention, care gaps, data integrity, and making healthcare actually work for more people—this one’s for you. Chapters 00:00 — Boombostic Health “In the Wild” @ HLTH 2025 (Vegas) 00:45 — Baseball dads, real life, and the cost of ambition 02:05 — “Everyone should have access to diagnostics” (mission) 03:00 — Why the “Diagnostic Zone” is a signal moment 04:30 — The stat gap: labs drive decisions, not spending 05:45 — Why they started with HIV/STI (the hardest use case) 07:30 — Self-collection scale + what it unlocked for access 08:10 — PrEP friction: stigma + testing barriers (and the unlock) 09:45 — The Abbott at-home multiplex test: what’s new + why it matters 11:05 — Rapid vs lab: the real issue is data integrity + reporting 12:40 — What’s next: routine tests, chronic disease, wellness expansion 16:15 — AI, avatars, and “forecasting health like weather” 18:10 — Bradley’s lens: signals, patterns, and getting patients on the right interventions 20:34 — Wrap + why data in will determine everything #boombostichealth #hlth2025 #diagnostics #moleculardiagnostics #labtesting #preventivecare #publichealth #healthcareinnovation #digitalhealth #aiinhealthcare #stitesting

Healthcare is racing to be “AI ready.” But most of the industry is still trying to turn billing exhaust into strategy. In this episode, Bradley Bostic sits down with Ryan Leurck, Co-Founder & Chief Analytics Officer at Kythera Labs, to cut through the noise and get blunt about what actually makes AI work in healthcare. Because the truth is simple—and uncomfortable: If your data can’t be trusted by humans, it can’t be trusted by AI. And in healthcare, much of our data was never designed for the questions we’re now demanding it answer. Takeaways Why claims, EHR, and lab data weren’t built for strategy—and how that limits AI. The risk of modern AI: “AI is not always right, but it always sounds sure.” Why healthcare data is still optimized for coding and billing, not predictive insight. Kythera’s mission to “reduce the uncertainty in the use of healthcare data.” How leaders should think about “AI ready” without falling for hype. The reality of claims: a “big bag of receipts” that can mislead without expert context. A practical vision for AI inside provider orgs: agents that function like analysts/interns, not decision-makers. Chapters 00:00 Introduction to AI in Healthcare 01:23 Ryan Leurck's Journey from Aerospace to Healthcare 03:22 The Current AI Landscape and Its Misconceptions 06:54 Kythera Labs: Reducing Uncertainty in Healthcare Data 11:13 Challenges of Healthcare Data and AI Integration 18:03 Opportunities for AI in Healthcare 22:52 Kythera's Target Audience and Solutions 27:41 The Role of AI in Operational Efficiency 31:18 Data Privacy and Accessibility in Healthcare 34:30 The Future of AI in Healthcare #boombostichealth #healthcareai #healthdata #dataanalytics #digitalhealth #machinelearning #aiinhealthcare #healthtech #healthcareinnovation #valuebasedcare #patientoutcomes #healthcareleadership

Summary By the time most people hear “dementia,” their brain has been sounding the alarm for years. In this episode of Boombostic Health, Dr. John Showalter shares his journey from internist to healthcare technology innovator. He explains how AI and digital tools can support early detection and intervention for cognitive decline—before daily life starts to fall apart. The conversation highlights how lifestyle changes can improve cognitive health, why screening the brain should be as routine as checking blood pressure, and how integrating technology into healthcare systems can scale better outcomes. Real-life success stories show what’s possible when you catch problems early and give people a path to act. Takeaways Dr. Showalter’s journey from medicine to healthcare technology is inspiring. AI can enhance caregiver efficiency and patient care. Early detection of cognitive decline is crucial for effective intervention. Lifestyle changes can significantly impact cognitive health. Integration of technology into healthcare systems is essential for scalability. Personalized brain health action plans can improve patient outcomes. Social isolation and loss of purpose are key factors in cognitive decline. Real-life success stories demonstrate the effectiveness of early intervention. Healthcare innovation requires collaboration between technology and clinical expertise. The future of cognitive health lies in proactive, lifestyle-based approaches. Chapters 00:00 Innovating Healthcare: A Journey into Technology 02:39 The Role of AI in Patient Care 05:34 Cognitive Health: Early Detection and Intervention 08:24 Lifestyle Changes and Cognitive Decline 11:07 Integrating Technology into Healthcare Systems 14:08 The Future of Cognitive Health and AI 17:03 Real-Life Success Stories in Cognitive Health About Dr. Showalter Dr. John Showalter is an internist and clinical informatics leader who has been obsessed with the data side of care since his first DNA research job at 14. Trained in biomedical engineering and medical informatics, he went on to lead major EHR implementations and build a state-of-the-art analytics center from a $0 to $6.5M budget, earning a Premier 100 IT Leaders award along the way. Today, he focuses on turning complex data and AI into practical tools clinicians actually use, helping detect disease earlier and improve patient outcomes at scale. Resources Linus Health – digital cognitive assessment and brain health platform: https://www.linkedin.com/company/linus-health/posts/?feedView=all Connect with Dr. John Showalter on LinkedIn: https://www.linkedin.com/in/johnshowaltermd/ Boombostic Health podcast – more episodes on AI, diagnostics, and the future of care: https://www.boombostichealth.com/podcast #dementia #brainhealth #earlydetection #aiinhealthcare #healthtech #cognitivehealth #boombostichealth #healthcareinnovation #healthcare

We keep acting like the mental health crisis and the spike in early-onset cancer are “mysterious.” They’re not. A huge chunk of the signal is sitting in your gut — and almost nobody in mainstream healthcare is looking at it. Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don’t account for it. Key Takeaways: * Why the microbiome is one of the most underused data layers in healthcare * How GutID turns gut health into a baseline, score, and trackable metric over time * How high-resolution microbiome data + AI unlock truly preventive diagnostics * Practical use cases: behavioral health, functional medicine, dietitians, and primary care * How gut data can inform smarter decisions around antibiotics and probiotics In this episode of Boombostic Health, I sit down with Paul Denslow, CEO & co-founder of Intus Bio, to unpack why gut health isn’t mystical, it’s a data problem and how GutID is turning the microbiome into an actionable signal for prevention, mental health, and early-onset cancer risk. Chapters 00:00 – Opening + why this conference feels different 02:29 – The microbiome as the “ocean” we’ve barely explored 03:22 – Mental health, early-onset cancer, and gut disruption 04:23 – GutID, data, and turning gut health into a measurable score 06:21 – How lifestyle and food systems are reshaping our bacterial “you” 06:59 – Where GutID is used today: DTC, behavioral health, functional medicine 07:56 – Antibiotics, probiotics, and why you need a microbiome baseline 13:54 – Why “all disease begins in the gut” is looking more true than ever 14:42 – Recommendations inside the GutID report (no supplement upsell) 16:06 – Paying with FSA and the path to employer and plan adoption 16:31 – Moving from diagnosis to the prevention window 17:18 – Gut toxins, long-term risk, and the smoking/heart disease analogy 18:20 – Science, capital, and scaling microbiome-driven prevention 18:48 – Closing + where to learn more about GutID and Intus Bio About our guest: Paul Denslow is the CEO and co-founder of Intus Bio, the company behind GutID. With a background in finance and big data, Paul partnered with co-founder Mark Driscoll, a pioneer in next-generation sequencing, to build a platform that treats the microbiome as a hard data problem—not a mystery. Intus Bio’s GutID test and Titan 1 platform are used by clinicians and practitioners to generate high-resolution microbiome data that can be translated into actionable prevention and disease insights. Links & Resources * Learn more about GutID: https://www.gutid.com/collections/all * Learn more about Intus Bio: https://www.intusbio.com/gutid * Watch more Boombostic Health episodes: https://www.boombostichealth.com/podcast #boombostichealth #guthealth #datadriven #healthtech #microbiome #preventativecare #cancer #mentalhealth #healthcare #healthcareinnovation

Virtual care is scaling. AI is everywhere. But when lab completion falls from ~70% in-clinic to ~30% in virtual care, the whole model breaks. Virtual Care Without Labs Is Just Zoom - Even with AI. In this Boombostic Health in the Wild episode from HLTH 2025, Bradley Bostic sits down with Maitham Dib, founder of Junction, to unpack the "real" bottleneck: turning lab orders into lab results. They dig into how Junction: * White-labels lab infrastructure so any virtual or hybrid care model can deploy labs across all 50 states * Uses data from ~3.4 million lab tests annually to model what actually drives lab completion * Dynamically routes patients across PSC visits, at-home kits, and at-home phlebotomy - based on real-world behavior * Plugs into telehealth and AI agents that still need working diagnostic rails to be useful Chapters 00:00 – Lab in the basement, but core to care 02:00 – 70% in-clinic vs. ~30% virtual: the lab completion cliff 03:30 – Junction’s white-label “Amazon-style” lab experience 06:30 – Three modalities: PSC, at-home kits, at-home phlebotomy 08:20 – “Where is the software actually?” Models on 3.4M lab tests 09:40 – Doctors, AI agents, and the diagnostic infrastructure layer 11:00 – Telehealth, pharma, and diagnostics as a new access door 12:40 – Business model: a new cost in a system that hates new costs Key Takeaways * Virtual care without completed labs is just Zoom. When fulfillment drops from ~70% in-clinic to ~30% in virtual, diagnosis and revenue leak out. * The real AI bottleneck is diagnostics.Agents and navigation tools only work if they can talk to lab infrastructure that actually gets tests done. * Infrastructure beats slogans.White-labeled, data-driven lab rails that convert orders to results are where virtual care and AI either succeed—or quietly fail. #boombostichealth #virtualcare #telehealth #digitalhealth #digitalhealthcare #healthcareinnovation #aiinhealthcare #patientcare #valuebasedcare #healthcare

Virtual care isn’t a feature. It’s the future care model nobody in healthcare wants to admit is already here. This conversation exposes three uncomfortable truths in healthcare: 1. Access is still broken. Millions delay care because transportation, work schedules, stigma, or geography get in the way. 2. Telemedicine wasn’t enough. Single-visit, transactional virtual care doesn't build trusted relationships, close care gaps, or keep patients inside a system of care. 3. Health systems are missing billions in preventable leakage. Ovation’s “digital health home” model quietly fixes that. At HLTH 2025, we sat down with Michael Dalton, CEO and founder of Ovatient, to unpack the real story behind why rural and urban patients alike are falling through the cracks and how Ovatient built the first truly integrated virtual multi-specialty practice on Epic. Dalton breaks down why: • A virtual-first care model that’s integrated directly into Epic makes specialists accessible within hours, not months • 95% of patients can be supported at home while still remaining inside their health system • Weight management, behavioral health, primary care, and specialty care all operate seamlessly across one unified patient journey • Virtual care isn’t cannibalizing brick-and-mortar — it’s expanding the funnel If you care about access, equity, referral management, or the economics of keeping patients connected to a system of care… this episode will challenge everything you think you know about “telemedicine.” Chapters 00:00 Introduction to Ovatient and Its Purpose 01:49 The Virtual Multi-Specialty Care Model 05:36 Integration with Health Systems 09:19 Building Trust in Healthcare 12:29 Closing Care Gaps with E-Consults Learn more: https://ovatient.com/ https://www.boombostichealth.com/ If you care about access, equity, referral management, or the economics of keeping patients connected to a system of care… this episode will challenge everything you think you know about “telemedicine.” Ovatient isn’t building a digital front door. They’re building the digital health home. And it’s changing the game. 🎧 Listen now and rethink everything you thought “virtual care” meant. #hlth2025 #boombostichealth #healthcareinnovation #virtualcare #healthsystems #digitalhealth #futureofcare #accesstocare

AI will accelerate healthcare — but genomics will rewrite it. The minute DNA drives care decisions for everyone, the current system becomes obsolete. Gene by Gene quietly runs one of the most advanced, high-throughput genomics labs in the world — powering platforms like MyHeritage and rapidly transforming clinical medicine, oncology, pharmacogenomics, and ancestry. This conversation explores what happens when every person leaves the hospital with a genomic passport — a lifelong DNA profile they own, control, and use to prevent disease before it begins. This is preventive medicine at scale. Not someday — now. What You’ll Learn - Why the genomics industry just flipped overnight - How AI + sequencing will routinely identify disease risk decades early - What happens when every patient controls their genomic data - How pharmacogenomics improves medication safety and outcomes - Why the healthcare system can’t keep up with genomic progress Chapters 00:00 – Live at HLTH 2025 00:29 – The quiet giant behind global genomics 01:20 – From physician to entrepreneur 02:45 – Acquiring Gene by Gene 04:19 – The massive shift to whole-genome sequencing 05:59 – Why more data = better diagnosis and prevention 07:30 – DecisionRx partnership and real-world outcomes 08:19 – Cost, speed, and modularity as the winning edge 09:52 – Sequencing every newborn at birth 11:00 – Data democratization and genomic ownership 11:59 – AI + 3 billion base pairs: why machines must lead 13:24 – Polygenic risk scoring and preventive cardiology 15:38 – Cognitive health and early-intervention models 16:40 – Nutrition + genomics: personal story 17:50 – Sleep, diet & medication metabolism 18:25 – Closing thoughts and future collaboration Learn more: https://www.boombostichealth.com/ https://www.genebygene.com/ #genomics #precisionmedicine #boombostichealth #DNARevolution #healthcareinnovation #futureofhealthcare #preventivemedicine #healthtech #biotechnology #artificialintelligence

Pharma Isn’t Broken — Access Is | ixlayer x Sanofi Ventures @ HLTH 2025 Patients don’t suffer because we lack medical innovation — they suffer because it takes too long to access it. 🚀 Why This Matters Patients today are consumers — they expect speed, personalization, and access. Pharma, technology, and venture capital are aligning to deliver it. The future of healthcare is collaborative, data-driven, and patient-first. Live from HLTH 2025 in the Diagnostic Zone, we dig into the real barriers between patients and lifesaving therapies. This episode covers: - How digital platforms reduce barriers to treatment - How AI is fueling proactive, personalized care - Why strategic capital accelerates patient-impact innovation Featuring: Pouria Sanae — Co-Founder & CEO, ixlayer Cris De Luca — Sanofi Ventures ⏱️ Timestamps 00:00 — Live at HLTH: Rethinking the pharma-patient connection 02:18 — Why patient access is the real bottleneck 04:20 — Sanofi Ventures: inside the strategic innovation model 06:45 — The truth about time-to-treatment in America 08:40 — The evolution of ixlayer & diagnostics infrastructure 10:30 — Can big pharma really go patient-first? 12:00 — Evidence, outcomes & trust in AI + health tech Connect & Learn More ixlayer.com - Revolutionizing patient access to diagnostics & treatment sanofiventures.com - Leading global strategic healthcare venture fund boombostichealth.com - Conversations at the edge of healthcare innovation 🎧 Listen & Subscribe Never miss an episode where we challenge the status quo in healthcare and spotlight the innovators building what’s next. 🧠 Healing Healthcare™ starts with bold ideas — and the courage to build them. #healthcareinnovation #digitalhealth #patientaccess #boombostichealth #aiinhealthcare #healthtech #pharmainnovation #futureofhealthcare #hlth2025 #hlthusa #PrecisionMedicine

Prescription costs are broken — and patients are the ones paying the price. In this episode of Boombostic Health, host Bradley Bostic sits down with Lathe Bigler of First Data Bank to unpack why e-prescribing hasn’t evolved in decades, how opaque pricing keeps patients in the dark, and why the next wave of pharmacy network innovation could flip the power dynamic back to patients. 💡 What We Cover: Why patients are frustrated with rising prescription costs How transparency empowers patients with real choices What most people don’t know about paying cash for prescriptions How e-prescribing networks can break pharmacy bottlenecks The role of technology in creating competition — and lowering costs This isn’t just about convenience. It’s about rebuilding trust in the healthcare system. Chapters 00:00 Introduction to Boombostic Health and Conference Atmosphere 08:23 Innovations in e-Prescribing Networks 14:59 The Importance of Transparency and Choice in Healthcare #boombostichealth #healthcareinnovation #PrescriptionTransparency #digitalhealth #patientempowerment #healthcaretechnology #prescriptioncosts #FirstDataBank #healthcaretechnology #healthcareleadership

Day 2 of #HLTHUSA in Las Vegas brought incredible energy, inspiring conversations, and some of the brightest minds in healthcare innovation. We took Boombostic Health: In the Wild onto the show floor to talk with leaders who are challenging the status quo and reimagining what’s possible in healthcare — from AI and data infrastructure to precision medicine, virtual care, and beyond. 🎙️ Featured Guests: - Lathe Bigler, General Manager, FDB Vela - Dr. Toby Basey-Fisher, CEO, Entia - Michelle Zimmerman, CEO, Previvor Edge - Dr. Geoffrey Rutledge, Cofunder & Chief Medical Officer, HealthTap - Bob Watson, CEO, Health Gorilla - Simon Arkell, CEO, Ryght.ai - James York, Chief Commercial Officer, Molecular Testing Labs - Fawad Butt, CEO, Penguin AI Each guest brought a unique perspective on how technology, leadership, and bold thinking are reshaping the business of healthcare. ✨ Filmed live at HLTH in Las Vegas — where the future of healthcare is being imagined and built. #boombostichealth #HLTH2025 #HLTHUSA #healthcareinnovation #futureofhealthcare #leadership #aiinhealthcare #digitalhealth #healthtech #innovation #lasvegas #healthcareleadership

Summary This conversation explores the transformative potential of AI in healthcare, emphasizing the importance of agentic AI, interoperability, and the need for a shift in medical education. The speakers discuss the challenges and opportunities presented by AI technologies, the necessity of upskilling healthcare professionals, and the economic models that must evolve to support these changes. They highlight the importance of viewing information as an asset and the role of AI in enabling personalized, longitudinal care for patients. Takeaways - There's always a new challenge to overcome in healthcare. - Mistakes often provide the best learning opportunities. - Agentic AI is set to transform healthcare significantly. - AI should enhance, not replace, human interaction in care. - 80% of clinicians' time is spent on administrative tasks. - Interoperability is crucial for effective patient care. - AI can synthesize vast amounts of data for better outcomes. - Investment in healthcare needs to focus on outcomes, not just costs. - Medical education must evolve to prioritize preventive care. - AI can turn healthcare from episodic to longitudinal care. Sound Bites "You learn so much more often from your mistakes." "AI allows us to synthesize a lot more data." "Information is ultimately an asset." Chapters 00:00 The Knothole Metaphor: Personal Drive and Motivation 02:57 Transformational Technology: The Impact of Agentic AI 05:38 AI in Healthcare: Redefining Roles and Responsibilities 08:43 Interoperability: The Key to Better Clinical Care 11:50 AI Integration: Upskilling and Workflow Automation 14:39 AI Native Applications: The Future of Healthcare Technology 17:42 Longitudinal Care: The Role of AI in Patient Management 20:32 Investment in Healthcare: Shifting Economic Models 23:37 The Future of Medical Education: A New Paradigm 26:31 Conclusion: The Bright Future of AI in Healthcare #healthcare #ai #agenticai #interoperability #medicaleducation #technology #patientcare #healthcaretransformation #digitalhealth #boombostichealth

Giving AI a ‘maternal instinct’ sounds strange… but it raises a real question: who decides how AI thinks in healthcare? 🧠 “Maternal instinct” for AI? Smarter than us… but will it care? ⚡ The first time in history we’ve built something more intelligent than ourselves. 💡 Who decides how it thinks — and whether it protects patients? 🔎 Why most AI initiatives in healthcare are failing. 🔥 No-code solutions + human oversight may be the only guardrails we have. #BoombosticHealth #AI #HealthcareInnovation #DigitalHealth #HealthTech #AINative #hc1

The business of healthcare is broken — but artificial intelligence might finally fix it. In this episode of Boombostic Health, Bradley Bostic and Jason Wenell reveal how to build an AI-ready healthcare system that learns, adapts, and delivers real value. Jason shares his three-layer framework — upskill people, automate workflows, and build AI-native systems that think. Discover how AI is becoming the engine behind value-based care and what it means for the future of healthcare innovation. Takeaways - AI is revolutionizing healthcare and other industries. - Value-based care relies heavily on data and predictive analytics. - AI can help identify social determinants of health. - Upskilling healthcare professionals is crucial for AI integration. - AI native applications will define the future of healthcare technology. - Data is considered the new oil in the healthcare sector. - Personalized healthcare will improve patient outcomes significantly. - AI should enhance human capabilities, not replace them. - Ethical considerations in AI development are paramount. - The future of healthcare is promising with the right AI applications. Chapters 00:00 Introduction to AI in Healthcare 03:13 AI Applications in Value-Based Care 06:04 Navigating Change Management in Healthcare 09:00 The Shift to AI Native Applications 11:49 Data as the New Oil in Healthcare 15:00 Personalized Healthcare Through AI 18:05 Transitioning to AI Native Solutions 20:59 Ethical Considerations in AI Development 24:05 The Future of Human-Centric Healthcare www.boombostichealth.com https://linktr.ee/BradleyBostic www.hc1.com linkedin.com/in/bradleybostic #boombostichealth #aihealthcare #healthcare #digitalhealth #healthcareinnovation #healthtech #valuebasedcare #ai

Why over 100 million Americans don’t have a primary care doctor, and how that drives up costs and worsens outcomes. In this conversation, Craig Hittle discusses the evolving nature of telemedicine, emphasizing that it should not be viewed merely as a transactional service. Instead, he advocates for a model that fosters long-term relationships between patients and healthcare providers, enhancing the overall quality of care delivered through digital platforms. Chapters 00:00 Introduction to Health Tap and Primary Care Innovations 04:16 The State of Primary Care in America 05:08 The Rise of Telemedicine and Its Impact 09:30 Telemedicine: A Shift in Patient Care Dynamics 12:39 Understanding the Durbin Report and Its Implications 15:35 Chronic Condition Management and Telehealth 17:58 The Role of AI in Enhancing Patient Care 21:11 Genomic Information in Primary Care 24:16 The Future of Telemedicine and Patient Relationships 28:26 Challenges and Opportunities for Primary Care Doctors 34:08 Value-Based Care: Aligning Incentives for Better Health 36:18 Sequence 01.mp4 Takeaways - Telemedicine is often misunderstood as purely transactional. - The goal of telemedicine should be to build relationships. - Long-term relationships with providers can improve patient care. - Telemedicine can enhance accessibility to healthcare services. - Establishing trust is crucial in telehealth interactions. - Patients should feel connected to their providers through telemedicine. - Digital health platforms can facilitate ongoing care. - The future of healthcare includes a blend of in-person and virtual visits. - Effective communication is key in telehealth. - Telemedicine can lead to better health outcomes when used correctly. #telemedicine #healthcareinnovation #boombostichealth #digitalhealth #digitalhealthcare

Every year in the U.S., 275,000 people die because of medication mismanagement — a failure that drains $528 billion annually from our $5 trillion healthcare system. It’s healthcare’s deadly hidden failure. That’s where DecisionRx comes in. Their coined Medication Therapy Optimization (MTO) approach goes far beyond Pharmacogenetics (PGx), combining AI-powered insights with pharmacist-led care to stop the guesswork, lower risk, and deliver results at scale. “The $528B isn’t in pill prices. It’s in ER visits, hospital admissions, and complications that never had to happen.” — Mike Tilton In this episode, host Bradley Bostic sits down with Mike Tilton, Chief Growth Officer at DecisionRx, to unpack the problem and spotlight the fix that’s delivering: - 8–10% reduction in total healthcare costs - 94% patient satisfaction - Maximum savings with minimal abrasion What You’ll Learn - Why $528B is being lost annually to preventable medication mismanagement. - How DecisionRx’s MTO model fixes the problem holistically — not just by swapping pills. - Why ER visits, hospitalizations, and complications drive the real costs. - Randall’s story: from 18 prescriptions and $12K/month to a sustainable regimen that restored his health. - How DecisionRx’s shared-savings model makes adoption possible even for financially strapped health systems. 📌 Episode 43 Chapters 00:00 – Intro: The $528B Fix 00:26 – 275,000 Preventable Deaths 01:57 – Mike Tilton’s Path to DecisionRx 04:44 – Healthcare’s $5T Problem 06:20 – Where $528B in Savings Hides 09:21 – MTO: Beyond Guessing Meds 12:59 – Randall’s Story 18:47 – Shared-Savings Model 22:49 – 94% Patient Satisfaction 26:31 – The Future: Concierge Pharmacy 31:27 – Closing: From Guesswork to Precision Medication mismanagement is killing us. DecisionRx has the fix. 👉 Learn more at decisionrx.com Subscribe to Boombostic Health for bold conversations that expose healthcare’s failures — and the solutions that can finally change it. #BoombosticHealth #valuebasedcare #MedicationOptimization #medicationsafety #pharmacogenomics #patientsafety #HealingHealthcare #healthcareinnovation #healthtech #digitalhealth #futureofhealthcare #healthequity

What is Real-World Data (RWD) in Medical Devices? It’s the information collected from everyday care — electronic health records, procedure notes, even how devices are used in emergencies — not just from controlled clinical trials. Why it matters to you: RWD shows how devices actually work in real people, not just in ideal test groups. - It helps doctors discover new ways to use existing devices — sometimes saving lives in unexpected situations. - It keeps life-saving tools on the market by proving their value, even when running huge clinical studies would be too costly. - It means safer, faster innovation — so patients benefit sooner. 👉 Without RWD, some devices could disappear simply because it’s too expensive to prove they work. With RWD, we protect access to life-saving care and give patients better outcomes. Pre-market clinical trials are essential — but they don’t reflect how devices truly perform once they’re in the real world. In this episode of Boombostic Health, host Bradley Bostic sits down with Dr. Amelia Hufford, Co-Founder and SVP of Clinical and Regulatory Science at 3Aware, to unpack why real-world data (RWD) is critical to the survival of medical devices — and why mindset, not science, may be the biggest barrier holding MedTech back. Amelia shares her 20+ year journey in scientific and clinical research, including a decade in MedTech leading regulatory and clinical affairs. She explains how RWD fills the gaps left by clinical trials, supports post-market surveillance, uncovers off-label use, and even opens the door to label expansion — giving manufacturers faster, less costly ways to prove safety and effectiveness. The conversation dives into the risks of ignoring RWD, the opportunities it creates for innovation and revenue, and how this shift could save one-third of devices currently at risk of disappearing from the market. What You’ll Learn in This Episode - Why pre-market clinical trials don’t fully reflect everyday device usage. - How real-world data provides insights into broader and more diverse patient populations. - Why manufacturers fear off-label data — and how it can actually unlock new markets. - The importance of treating RWD studies with the same rigor as traditional clinical research. - How RWD can accelerate innovation, improve patient outcomes, reduce costs, and support regulatory compliance. Why It Matters Without embracing real-world data, the MedTech industry risks losing critical devices — some of which save lives in high-stakes scenarios. By shifting mindset and using RWD with scientific rigor, manufacturers can not only ensure patient safety but also unlock growth opportunities, accelerate label expansion, and meet regulatory demands more efficiently. Resources & Links Learn more about 3Aware: https://3aware.ai/ Connect with Dr. Amelia Hufford on LinkedIn: https://www.linkedin.com/in/amelia-hufford-46181020/ Follow Bradley Bostic on LinkedIn https://www.linkedin.com/in/bradleybostic/ Subscribe on LinkedIn for weekly newsletter: https://www.linkedin.com/newsletters/7259254152554250241/ #medtech #RealWorldEvidence #healthcareinnovation #medicaldevices #3Aware #boombostichealth #rwe

The Dangerous Reality of Maternal Care in America. Did you know up to 80% of mothers are anemic by the 3rd trimester? And Black & Native mothers die at 49.5 per 100,000 births vs 19 for white mothers. These risks are preventable—yet our system still misses them. Giving birth in the U.S. is riskier than it should be. - 18% of mothers show anemia in the 1st trimester - By the 3rd trimester, that number explodes to 80% - Black & Native mothers: 49.5 deaths per 100,000 births - White mothers: 19 per 100,000 births Why It Matters Every statistic in this episode represents mothers, babies, and families forever changed. Tiffany’s message is clear: maternal deaths and injuries in the U.S. are preventable—but only if we address hidden risks early and make proactive care the standard. Chapter Highlights: 00:00 – Intro & Guest 01:57 – Tiffany’s Background 04:46 – Mothers & Babies at Risk 05:29 – Broken U.S. Care System 08:18 – 49.5 vs 19: The Disparity 10:09 – Hidden Risk: Anemia 11:57 – How HerCare Works 19:23 – Awareness & Policy Change 22:07 – The Future of Maternal Care 27:56 – Closing & Takeaways In this episode, Bradley Bostic sits down with Tiffany Hall, nurse and Director of cPBM Clinical Technology at hc1, to uncover the hidden pregnancy risks fueling maternal deaths — and how HerCare powered by MyBloodHealth helps providers act earlier to save both mothers and babies. 👉 What do YOU think needs to change first: policy, technology, or provider workflows? What You’ll Learn in This Episode: 📊 The shocking stats: anemia’s rise from 18% in the 1st trimester to 80% by the 3rd ⚠️ How anemia fuels hemorrhage, cardiovascular problems, and postpartum depression ✊ Why Black and Native mothers face mortality rates more than 2X higher than white mothers 🧪 How lab-driven insights can flip care from reactive to proactive 💡 How HerCare simplifies provider workflows and closes dangerous gaps in maternal care #pregnancy #maternalcare #maternalmortality #pregnancyrisks #healthcareinnovation #boombostichealth #MyBloodHealth #pregnancyjourney #pregnant #maternalcare #maternalhealth

AI in healthcare isn’t about robot doctors — it’s about building billion-dollar businesses. In this episode of Boombostic Health, Bradley Bostic sits down with Nigel Ohrenstein, CEO of Diagnostic Robotics and veteran healthcare entrepreneur, to explore how agentic AI is quietly reshaping the $4T healthcare industry. Nigel has taken companies from napkin sketch to multi-billion-dollar scale — most notably co-founding Lumeris and now leading Diagnostic Robotics. He shares what it really takes to scale in healthcare, why execution matters more than ideas, and how AI is transforming the 80/20 rule: shifting clinicians’ time from endless paperwork back to patient care. Together, they unpack: Why AI in healthcare isn’t about replacing doctors — it’s about unlocking billion-dollar impact. How Nigel scaled Lumeris into a multi-billion-dollar company and the lessons he carried forward. The role of agentic AI in automating administrative tasks and enabling faster, cheaper, and higher-quality care. Why the next wave of healthcare innovation will be built by operators who understand both incentives and execution. The untold story of scaling companies in a $4T industry under massive pressure to change. Chapters 00:00 Introduction to Diagnostic Robotics and Nigel's Journey 08:37 The Drive Behind Innovation in Healthcare 16:56 Understanding Agentic AI in Healthcare 25:31 AI in Healthcare: Streamlining Administrative Tasks 29:00 Transforming Patient Engagement and Care Quality 30:51 Lessons from John Doar: Execution and Preparation 36:50 The Role of Technology in Healthcare 46:13 Innovation Under Pressure: Opportunities in Healthcare 👉 Whether you’re a healthcare leader, entrepreneur, or investor, this episode will give you a candid, insider’s look at how AI is powering the next generation of billion-dollar healthcare businesses. Listen now and learn why the future of healthcare belongs to those who can scale with AI. Keywords #BoombosticHealth #aihealthcare #healthcareinnovation #ai #digitalhealth #futureofmedicine #futureofhealthcare #aihealth

⚡Pee in a Cup. Detect Cancer. Save Lives. Sounds crazy, right? But it’s REAL. 👉 Learn how a urine test powered by AI can detect multiple cancers with jaw-dropping accuracy. Host Bradley Bostic sits down with Curtiss McNair Jr., VP of Operations at PanGIA Biotech, to explore a medical breakthrough that could transform cancer detection worldwide. 🔑 The Science: How AI-powered urine testing is achieving 96% sensitivity and 74% precision in detecting multiple cancers. 🔑 The Impact: Why this innovation could eliminate unnecessary biopsies and finally make early cancer screening accessible to all. ⏱️ TIMESTAMPS: 0:00 – Urine Test for Cancer?! 2:30 – Why 2/3 of biopsies are unnecessary 7:45 – ASCO results: 96% sensitivity explained 12:30 – How AI makes this possible 18:00 – The global rollout: India to the U.S. 22:00 – Leadership in healthcare: why breakthroughs fail without it 🌍 Why It Matters Millions face late-stage diagnoses because screenings are invasive, expensive, or inaccessible. This technology flips the script: a simple urine sample could save lives. And beyond the science, strong leadership is what ensures breakthroughs actually reach patients. 🤔 Why You’ll Share This ⚡Because everyone knows someone touched by cancer. ⚡Because a urine test is so simple, it feels unreal. ⚡Because it could literally save millions of lives. Would you take a pee test for cancer instead of a biopsy? Drop your answer in the comments 👇 🔔 Subscribe to Boombostic Health for more bold ideas that challenge the broken business of healthcare. #AIHealthcare #MedicalAI #HealthTech #ArtificialIntelligence #DigitalHealth #MedicalBreakthrough #HealthcareInnovation #FutureOfMedicine #LifeSavingTech #HealthNews #BoombosticHealth #CancerDetection #CancerResearch #CancerScreening #BiopsyAlternative

🚕 Healthcare needs its Uber moment. Here’s what that means. 💡 The secret to healthcare adoption? Solve the hassle. ⚡ What Uber taught us about fixing healthcare. 🔎 Healthcare’s “Uber moment” explained in 40 seconds. 🔥 Why patients need Uber-level experiences in healthcare. #BoombosticHealth #digitalhealth #healthcareinnovation #venturecapital

What does it really take to build and scale a healthcare company? In this episode of Boombostic Health, Bradley Bostic sits down with Lee Shapiro—Managing Partner at 7wire Ventures, former President of Allscripts, and co-founder of Livongo—to talk about his journey from “recovering lawyer” to building one of the most successful companies in digital health. Lee shares how he and Glenn Tullman grew Livongo into a public company and ultimately merged with Teladoc in a landmark $18.5 billion deal. He breaks down why healthcare innovation is never an overnight success, how to spot “Uber moments” in healthtech, and why solving consumer hassles is the future of care. Whether you’re an entrepreneur, investor, or operator, this conversation offers a masterclass on building meaningful healthcare businesses that last. Key Moments 00:00 – Intro: Bradley Bostic welcomes Lee Shapiro of 7wire Ventures 01:40 – From lawyer to entrepreneur: Why Lee left law to build companies 05:20 – Allscripts and the early days of digital health 10:30 – The Livongo story: 6-year grind to IPO and $18.5B Teladoc merger 13:50 – The B2B2C model in healthcare explained 15:20 – Consumer hassle mapping: Finding healthcare’s “Uber moments” 17:20 – Value-based care & empowering the patient 19:40 – Scaling through M\&A: The $620M Accolade–Transcarent deal 25:30 – How 7wire Ventures supports portfolio founders beyond capital 29:20 – Doing well by doing good: Investing with purpose in healthcare 31:10 – Cubs or Sox? Lee’s Chicago roots and final thoughts Key Topics * Digital health entrepreneurship * Venture capital in healthcare * How Livongo scaled to an $18.5B deal with Teladoc * The future of value-based care * Consumer hassle mapping and patient empowerment * Healthcare M&A and scaling strategies Connect: 🎙️ Subscribe to Boombostic Health: https://www.youtube.com/@BoombosticHealth 📩 Subscribe on LinkedIn https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7259254152554250241 🔗 Follow Bradley Bostic on LinkedIn: https://www.linkedin.com/in/bradleybostic/ 🌐 Learn more about 7wire Ventures: https://www.7wireventures.com/ #DigitalHealth #HealthcareInnovation #VentureCapital #Livongo #Teladoc #BoombosticHealth

Ovaries age faster than nearly every other organ in the body. Women are born with every follicle they’ll ever have — and science can now predict how quickly that reserve is depleting. What would you do with that knowledge? #menopause #ovarianhealth #perimenopause #fertility #womenshealth #boombostichealth #lifeahead

What if women could know years in advance when perimenopause and menopause will begin? Bradley Bostic talks with Nich Gentry and Dr. Lizellen La Follette of Life Ahead, the startup combining ultrasound, personalized data, and validated science to predict menopause timing and improve women’s health outcomes. 00:00 – Why Proactive Healthcare Matters: Shifting from reactive to proactive care in women’s health. 01:14 – Meet Life Ahead: Nich and Dr. Lizellen share their mission to close the women’s health gap. 04:11 – Understanding Ovarian Aging: Why ovaries age faster than most organs and what it means for overall health. 08:16 – Perimenopause Explained: What it is, symptoms, and why timing matters. 10:11 – The Cost of Waiting: How early menopause prediction could save money and improve health outcomes. 12:41 – The Science Behind the Tool: From NSF funding to Yale mathematicians — the breakthrough research journey. 14:43 – The Startup Rollercoaster: Highs, lows, and challenges of building a new category in healthcare. 27:17 – WHOOP, Fitness, and Sleep: Why tracking recovery and lifestyle metrics is part of better healthcare. 30:17 – Looking Ahead: Envisioning the future of women’s health through predictive technology. To learn more or join the waitlist visit: https://lifeahead.co/ You’ll learn: How ovarian aging reveals early signs of overall health decline. Why predicting menopause could help prevent bone loss, cognitive decline, and other age-related issues. The groundbreaking science behind Life Ahead’s algorithm. Why women’s health research has been historically underfunded — and how to change it. The challenges and wins of building a science-backed health tech startup. Whether you’re a healthcare professional, innovator, or advocate for women’s health, this conversation will show you how proactive care can transform lives. #menopause #womenshealth #perimenopause

Guest: Melissa Butterworth, CEO of Advanced Strategic Partners Overview: Hospitals are under extreme financial pressure—but what if the answer to their budget woes is sitting right inside their own labs? In this eye-opening episode, Melissa Butterworth—who’s led over $2.4 billion in lab transactions—joins Bradley to explore the growing trend of health systems divesting lab assets. Together, they unpack: - Why hospitals are selling even profitable lab outreach operations - How to accurately assess the real value of a lab business - What happens post-sale—and how to unlock even more value with AI-powered lab insights - The strategic partnership between ASP and hc1, and how it’s driving next-gen transformation Chapters: 04:30 Melissa's story: from LabCorp exec to M&A powerhouse 07:20 Why lab outreach programs are being sold off—even with 40%+ margins 10:50 “Compressed value”: What hospital labs are really worth to buyers like LabCorp or Quest 15:40 The rise of AI in lab-driven personalized medicine 17:45 Predicting Alzheimer’s from routine labs? It’s already happening. 17:55 The Role of Labs in Future Healthcare Key Quote: “It’s just as hard to play small as it is to play big. So why not go big?” – Bradley Bostic

In this episode, host Bradley Bostic sits down with healthcare innovator and author Jim Wallace to discuss how AI, wearables, genomics, and big data are transforming the way care is delivered. Wallace shares insights from his new book, Precision Medicine, AI, and the Science of Personalized Health Care, revealing why traditional models of care are falling short—and what’s next. What you’ll learn: - Why 53% of medications don’t work as intended - How social support increases patient survival by up to 50% - Where healthcare investment is missing the mark - What the Alice Walton School of Medicine is doing differently - How AI is closing critical care gaps from anemia to cancer Chapters 00:00 Introduction to Value-Based Care and AI 04:57 The Journey to Personalized Healthcare 11:12 AI's Role in Transforming Healthcare 18:25 The Importance of Preventive Medicine 25:49 Innovations in Medical Education 33:58 The Future of Healthcare and AI

In this episode of Boombostic Health, host Bradley Bostic speaks with Greg Stein, CEO of Shadowbox, about the challenges and innovations surrounding electronic health records (EHRs) and lab test ordering. They discuss the limitations of traditional EHR systems, the innovative solutions Shadowbox provides to streamline lab test ordering, and the broader implications for diagnostics and patient care. The conversation also touches on community health initiatives, the importance of interoperability in healthcare, and the potential for partnerships to enhance healthcare delivery. Takeaways - The business of healthcare is fundamentally broken. - Shadowbox offers an innovative solution for lab test ordering. - Faxes are still prevalent in healthcare communications. - Shadowbox has achieved a 20% reduction in denials for labs. - The Shadowbox system can be applied to various diagnostics, not just labs. - There is a significant opportunity to flag patients for clinical trials. - Healthcare interoperability is a $950 billion problem. - No single solution fits all healthcare interoperability needs. - The time for healthcare innovation is now. - Partnerships can enhance healthcare delivery and patient outcomes. Chapters 00:00 Introduction to Electronic Health Records and Their Challenges 04:52 Innovative Solutions for Lab Test Ordering 09:05 Expanding Beyond Labs: Applicability to Other Diagnostics 12:22 Research Opportunities and Clinical Trials 16:22 Community Engagement and Public Health Initiatives 19:54 Understanding Interoperability and Integration Challenges 27:10 Partnerships and Future Directions in Healthcare

In this special “Best Of” episode, we bring together the boldest, most unforgettable moments from our five most-watched interviews on Boombostic Health. These leaders aren’t just talking about change—they’re making it happen. In just 30 minutes, you'll hear from entrepreneurs, investors, clinicians, and health system leaders who are all challenging the business of healthcare in radically different—and deeply personal—ways. Featured Guests: Chris Leeuw – After surviving a paralyzing spinal cord injury, Chris defied the odds, relearned to walk, and launched NeuroHope to build a more humane, patient-focused model of care. Adam Heller – Venture capitalist and founder of Oakwood Circle Ventures, Adam breaks down the economic dysfunction at the heart of healthcare and why capital must follow impact, not hype. Steve Serota – As a leader in lab medicine, Steve explains why treating cancer without subspecialized pathologists is a dangerous norm—and what needs to change now. Matt Honan – A diagnostics executive who reveals how a simple lab test can prevent costly surgical complications, while saving lives and driving smarter care. David Ohm – A nonprofit health system executive showing how AI can bring operational efficiency—and better care—to underserved populations, if applied with the right intent. What You’ll Learn: Why most spinal cord injury patients are abandoned by the system—and how NeuroHope is changing that The trillion-dollar inefficiencies strangling healthcare innovation How diagnostics can shift care from reactive to proactive The hidden power of pathology—and what happens when we ignore it Why AI in healthcare isn’t just about tech—it’s about equity, governance, and trust

In this episode, Bradley Bostic and James Maskell discuss the innovative approaches to addressing cognitive decline through functional and precision medicine. They explore the impact of environmental factors, particularly mold, on brain health, and the importance of a holistic approach to care. James shares his personal journey with his father's cognitive decline and how it led to the development of TruNeura, a revolutionary tool to allow any clinic to operate and scale a successful brain health protocol. The conversation highlights the need for a shift in healthcare models to better support aging populations and the potential for preventive measures in cognitive health. Takeaways  - Cognitive decline is a multifaceted issue influenced by environmental factors.  - Mold exposure can significantly impact cognitive health.  - Precision medicine offers a promising approach to reversing cognitive decline.  - TruNeura aims to integrate a multimodal approach to brain health.  - Holistic health programs can benefit seniors in living facilities.  - The healthcare system is slowly recognizing the importance of functional medicine.  - There is a growing demand for personalized cognitive health solutions.  - Understanding the prodromal period is crucial for early intervention.  - Community support plays a vital role in managing cognitive health.  - Preventive measures can start as early as age 30. Chapters 00:00 Introduction to Cognitive Decline Solutions 02:54 Personal Journey and Mold's Impact on Cognitive Health 06:39 Understanding Environmental Determinants of Health 09:27 The Role of Precision Medicine in Cognitive Health 13:09 Developing a Software Solution for Cognitive Care 15:32 Integrating Cognitive Health in Senior Living 18:00 Holistic Health Approach to Cognitive Decline 21:00 Challenges in Implementing New Health Models 23:49 The Future of Cognitive Health and Prevention

In this episode of Boom Bostic Health, host Bradley Bostic interviews James Maskell, a thought leader in functional medicine and health economics. They discuss Maskell's journey into the field, the challenges of conventional medicine, and the potential for reversing chronic diseases through lifestyle changes. The conversation also touches on the importance of community in health, the shift towards value-based care, and the future of cognitive health in the context of functional medicine. Takeaways - James Maskell's early exposure to alternative medicine shaped his career. - The medical system is not designed for chronic disease management. - Chronic diseases can be reversible with lifestyle changes. - Patient empowerment is crucial in reversing chronic illnesses. - Functional medicine focuses on the root causes of health issues. - Community support enhances health outcomes. - Value-based care incentivizes keeping patients healthy. - Loneliness is a significant factor in health outcomes. - Cognitive health can be improved with precision medicine. - Collaboration between conventional and functional medicine is essential. Chapters 00:00 Introduction to Functional Medicine and Longevity 02:39 James Maskell's Journey into Health Economics 05:42 Reversing Chronic Disease: A New Approach 08:23 The Evolution of Medicine and Entrepreneurial Ventures 11:06 Challenges in Conventional Medicine 13:51 Value-Based Care and Its Implications 16:43 The Role of Community in Health 19:32 Future of Cognitive Health and Functional Medicine